The India clinical trials market was valued at USD 1.66 Billion in 2025 and is expected to grow at a CAGR of 7.10%, reaching USD 3.30 Billion by 2035. The market is experiencing growth due to increasing outsourcing of clinical trials and supportive government regulations.
Base Year
Historical Period
Forecast Period
The growing emphasis on clinical trials related to cancer, diabetes, cardiovascular, and infectious diseases, is anticipated to boost the market growth in the forecast period.
Phase II and Phase III trials are expanding rapidly, with growth rates between 15% and 18%, which is likely to elevate the India clinical trials market value in the coming years.
The increasing adoption of digital and AI-driven technologies to optimise trial processeis is one of the major market trends.
Compound Annual Growth Rate
7.1%
Value in USD Billion
2026-2035
*this image is indicative*
The market is experiencing significant growth, driven by a combination of factors including a diverse patient population, cost-effective research solutions, and an evolving regulatory environment. The Indian government has been working to streamline clinical trial regulations, aiming to accelerate approval processes and improve the overall research environment, which is likely to elevate the market value. Moreover, rising investment in the development and maintenance of clinical trial sites is poised to bolster the market growth in the forecast period.
Increasing Disease Burden to Drive Market Growth
The increasing disease burden in India is one of the significant factors driving the growth of the clinical trials market. According to recent data from the Longitudinal Ageing Study in India (LASI), about 21% of the elderly population in the country suffers from at least one chronic condition, such as hypertension, diabetes, heart disease, and stroke. This growing prevalence of chronic diseases highlights a growing demand for innovative treatments, which is projected to fuel market growth.
The market is witnessing several trends and developments like improved clinical trial infrastructure and rising adoption of digital and AI technologies.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Phase
Market Breakup by Service Type
Market Breakup by Therapeutic Areas
Market Breakup by Application
Segmentation Based on Phase to Witness Substantial Growth
Based on the phase, the market is segmented into Phase I, Phase II, Phase III, and Phase IV clinical trials. The Phase III trial segment holds a high market share due to the large and diverse population of the country, providing the ideal environment for the extensive data collection needed in this study. These trials involve testing a drug on a large number of patients to confirm its effectiveness, monitor side effects, and compare it to existing treatments. Since these trials are essential for regulatory approval, they attract the largest portion of clinical trial investments.
The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
IQVIA is a global leader in clinical trials and has a strong presence in India. The company uses its IQVIA CORE™ platform, which combines technology and data to improve the design of clinical trials and predict trial outcomes. IQVIA supports a wide range of trials in India, including in areas like cancer, diabetes, heart diseases, and rare conditions.
Labcorp Drug Development provides end-to-end clinical trial services and is expanding its footprint in the India clinical trials market. The company offers clinical trial management, laboratory testing, and data analysis services to pharmaceutical companies. Labcorp supports India-based trials in a wide range of therapeutic areas, ensuring high-quality data collection and compliance with local and international regulations.
Parexel is a leading global provider of clinical research and regulatory services. In India, the company focuses on improving the speed and efficiency of clinical trials by offering services such as patient recruitment, data management, and regulatory consulting. Parexel also leverages technology to simplify trial processes and provide better access to patients.
Syneos Health is a biopharmaceutical solutions provider that accelerate the process of developing new treatments. In India, the company works with pharmaceutical and biotech companies to run clinical trials more effectively. Using its Syneos One® platform, which integrates clinical and commercial services, Syneos Health helps coordinate all aspects of clinical trials. They focus on areas like cancer, diabetes, and rare diseases, improving how quickly and efficiently new treatments reach patients in India.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Syngene International Limited, Charles River Laboratories, ICON plc, Aragen Life Sciences Ltd, and Aurigene Oncology.
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Phase |
|
| Breakup by Service Type |
|
| Breakup by Therapeutic Areas |
|
| Breakup by Application |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share